Climb Bio annual current ratio
2020
2021
2022
2023
2024
2025
Climb Bio Current Ratio Growth & History (CLYM)
Climb Bio's current ratio was 15.16 for fiscal 2025.
View full Climb Bio company overviewClimb Bio annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 15.16 | −16.25 | −51.74% |
| 2024 | 2024-12-31 | 31.41 | −7.51 | −19.30% |
| 2023 | 2023-12-31 | 38.92 | 16.88 | +76.56% |
| 2022 | 2022-12-31 | 22.04 | −2.54 | −10.33% |
| 2021 | 2021-12-31 | 24.58 | 17.40 | +242.27% |
| 2020 | 2020-12-31 | 7.18 | — | — |
Climb Bio quarterly current ratio
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 31.45 | 17.37 | +123.34% |
| Q1 2026 | 2026-03-31 | 27.86 | 13.60 | +95.45% |
| Q4 2025 | 2025-12-31 | 15.16 | −16.25 | −51.74% |
| Q3 2025 | 2025-09-30 | 18.38 | −39.35 | −68.16% |
| Q2 2025 | 2025-06-30 | 14.08 | −46.33 | −76.69% |
| Q1 2025 | 2025-03-31 | 14.25 | −22.77 | −61.51% |
| Q4 2024 | 2024-12-31 | 31.41 | −7.51 | −19.30% |
| Q3 2024 | 2024-09-30 | 57.73 | 18.97 | +48.95% |
| Q2 2024 | 2024-06-30 | 60.41 | 28.83 | +91.32% |
| Q1 2024 | 2024-03-31 | 37.02 | 12.57 | +51.43% |
| Q4 2023 | 2023-12-31 | 38.92 | 16.88 | +76.56% |
| Q3 2023 | 2023-09-30 | 38.76 | 17.55 | +82.77% |
| Q2 2023 | 2023-06-30 | 31.58 | 14.10 | +80.67% |
| Q1 2023 | 2023-03-31 | 24.45 | 5.12 | +26.51% |
| Q4 2022 | 2022-12-31 | 22.04 | −2.54 | −10.33% |
| Q3 2022 | 2022-09-30 | 21.21 | −7.17 | −25.27% |
| Q2 2022 | 2022-06-30 | 17.48 | −0.87 | −4.73% |
| Q1 2022 | 2022-03-31 | 19.33 | — | — |
| Q4 2021 | 2021-12-31 | 24.58 | 17.40 | +242.27% |
| Q3 2021 | 2021-09-30 | 28.38 | — | — |
| Q2 2021 | 2021-06-30 | 18.34 | — | — |
| Q4 2020 | 2020-12-31 | 7.18 | — | — |
Climb Bio current ratio trends
Over the last five fiscal years, Climb Bio's current ratio increased from 7.18 to 15.16, a change of 7.97. The latest reported quarter, Q2 2026, shows 31.45.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Climb Bio source filings ↗